Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of STAHIST in Seasonal Allergic Rhinitis
NCT01171664Phase 2Completed
- Sponsor
- Magna Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of chlorcyclizine and pseudoephedrine in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Magna Pharmaceuticals. Primary endpoint: Total Symptom Scores at 2 weeks. Started Sep 2010; status: completed.
02
Drugs
chlorcyclizinepseudoephedrine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01171664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171664.